Understanding the valuation of early-stage businesses and related intellectual property is critical for new business ventures. This information helps determine business strategy, financial modeling and the overall potential for a business.
Vanderbilt University signed an option and limited license agreement with KIYATEC, a company dedicated to commercializing 3D cell culture technologies.
BioNanovations, a startup company based on technology developed at Vanderbilt, claimed first place at the NewME Accelerator PopUp event held in Memphis June 28-30.
A good opportunity for new ventures in the life sciences industry opened today. The second annualLife Science Tennessee Venture Forumis now accepting applications for the 2013 competition.
Vanderbilt faculty, staff and students with innovative ideas and entrepreneurial aspirations will have additional support during the 2013-14 academic year.
An innovative wafer inspection tool developed by a team of Vanderbilt professors and engineers has been licensed exclusively to startup company Femtometrix.
The Wall Street Journal recently featured “organs on a chip”, an innovative practice that is helping researchers around the globe dive into a new world of drug discovery.
Congratulations to a Vanderbilt research collaborator on receiving Medicare approval of a diagnostic test for patients with advanced non-small cell lung cancer (NSCLC).